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Abstract 
Type	  2	  Diabetes	  (T2D)	  is	  the	  most	  common	  form	  of	  diabetes	  mellitus	  which	  
affects	  approximately	  8.3%	  of	  the	  popula@on	  (diabetes.org	  2013).	  T2D	  is	  
most	  oDen	  brought	  on	  by	  reduced	  sensi@vity	  to	  insulin	  receptors.	  This	  is	  
thought	  to	  be	  caused	  by	  a	  muta@on	  in	  the	  gene	  Insulin	  Receptor	  Substrate-­‐	  
1	  (IRS-­‐1).	  It	  is	  the	  suppression	  of	  IRS-­‐1	  that	  leads	  	  to	  inac@va@on	  of	  signaling	  
molecules	  insulin	  signaling	  pathways	  causing	  insulin	  resistance	  (Victor	  D.	  H.	  
et	  al).	  This	  literature	  review	  will	  focus	  on	  the	  major	  mechanisms	  of	  
inhibi@on	  of	  the	  insulin	  signaling	  pathways.	  Mice	  that	  were	  bred	  lacking	  the	  
Atk2	  signaling	  pathway	  (associated	  with	  IRS-­‐1	  gene)	  revealed	  age-­‐
dependent	  adipose	  @ssue	  loss	  and	  an	  increase	  in	  hyperglycemia.	  This	  
suggests	  that	  the	  Akt2	  pathway	  is	  crucial	  for	  glucose	  metabolism	  (Garofalo	  
2003;	  Guo	  2013).	  	  Future	  research	  will	  focus	  on	  ac@va@ng	  IRS-­‐1	  and	  Atk2	  as	  
a	  therapeu@c	  modality	  for	  the	  treatment	  and	  preven@on	  of	  type	  2	  diabetes	  
and	  other	  metabolic	  diseases.	  
Pathophysiology of Diabetes 
•  Insulin and glycogen are hormones produced in the pancreas and 
are the two main hormones involved in regulating the level of glucose 
in the blood. 
•  The pancreas contains about 1 million groups of cells called islets. 
There are two kinds of pancreatic islets: α (alpha) and β (beta) cells. 
Alpha cells secrete glycogen and β cells secrete glucagon.  
•  On a molecular level glucose homeostasis is triggered by a signaling 
cascade  
•  Atk2/IRS-1˃FOXO1>PEPCK 
•  T2D results from a combination of  increased insulin resistance due 
to reduced sensitivity to insulin receptors (i.e.  IRS-1) and prolonged 
deterioration of β cell function. 
Inactivation of the Insulin Growth Factor -1 (IGF-1) 
•  Insulin receptors and IGF-1 signaling affect 
pancreatic β cell functions in different ways via their 
actions on the IRS-1 and IRS-2. 
•  Mice were bred that lacked both the IGF-1 receptor 
in pancreatic β cells and either the IRS-1 or IRS-2. 
•  It was observed that the IGF-1/IRS-2 double mutants 
that by six weeks of age, the lack of the IGF-1 
receptor function aggravated the effects of IRS-2 
knockout resulting in diabetes. 
•  Inactivation of IGF-1/IRS-1 in pancreatic β cells 
impairs insulin secretion. 
•  Inactivation of IGF-1/IRS-2 impairs pancreatic β cell 
replication. 
Mutation in FOXO and PEPCK Gene(s) 
•   PEPCK Gene-(phosphoenolpyruvate 
carboxykinse) encodes for synthesis of 
glucose into the bloodstream. 
•  FOXO1 Gene- the transcription factor that 
promotes the expression of the PEPCK gene 
by binding to it. 
•  β cell –specific deletions on mice using Cre/
loxP-mediated  recombination were used  to 
assess FOXO-1 requirement in β cells. 
•  Deletion of FOXO-1 inhibits the transcription 
of PEPCK gene suppressing insulin 
production. 
Next Steps/Future Research 
• Activating IRS and Atk2 for future treatment and 
prevention of diabetes (Garofalo 2003; Guo 2013) 
• Demonstrate how signaling pathways can be 
modulated unfolding β cell failure (Shouhong et al 
2010). 
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Fig. 1 Glucose Homeostasis 
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IRS-1 and Atk2 Signaling Pathways 
•  Mice were bred lacking Atk2 signaling pathways 
which are associated with the IRS-1 gene. 
•  At 22 weeks of age loss of adipose (fat) tissue, 
increase in hyperglycemia (high blood sugar), 
and increased insulin resistance were 
observed.  
•  This suggests that the degradation of the Atk2 
signaling pathways causes the sensitivity of 
insulin receptors (e.g. IRS-1) to be reduced 
. 
•  This may be an important step in the 
development of insulin resistance/diabetes. 
Fig.	  3	  	  Comparison	  of	  inhibited	  signaling	  pathway	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  or	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Tell	  the	  reader	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  your	  
study	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• How	  does	  your	  work	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  with	  published	  literature?	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  is	  the	  significance	  of	  your	  findings?	  	  	  
• Make	  sure	  you	  have	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  the	  Hypothesis/Ques@ons/
Objec@ve	  you	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  earlier.	  	  
References	  
These	  can	  be	  in	  smaller	  font,	  for	  those	  who	  are	  interested.	  	  
Acknowledgements	  
Remember	  to	  thank	  your	  classmates,	  mentors	  other	  professors	  who	  contributed	  or	  
supported	  your	  work.	  Men@on	  any	  	  grants	  or	  fellowship	  that	  supported	  your	  work.	  
This	  can	  also	  be	  in	  a	  smaller	  font.	  	  
Descrip@ve	  Cap@on	  
Descrip@ve	  Cap@on	  
Descrip@ve	  Cap@on	  
